Skip to main content

Table 2 Key patient meta-data and derived cell line properties (adapted from Q-Cell database [35])

From: Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas

Cell line Patient age (years) Patient Survival (Days) RB pathway LOF Cell line doubling time (hours) XG median survival (days)
BAH1 75 94 Yes 79.5 ± 3.3 210 ± 8
FPW1 68 242 Yes 48.1 ± 4.7 196 ± 4
HW1 54 89 Yes 55.8 ± 2.7 174 ± 14
JK2 75 178 Yes 94.2 ± 4.5 147 ± 9
MMK1 80 334 Yes 52.4 ± 3.3 157 ± 15
MN1 84 36 Yes 44.9 ± 1.0 258 ± 20
PB1 57 39 Yes 79.4 ± 6.3 71 ± 1
RKI1 57 Alive (7 years) No 72.9 ± 5.3 248 ± 6
RN1 56 243 Yes 37.5 ± 1.9 81 ± 2
SB2b 48 420 Yes 108.7 ± 6.9 120 ± 3.3
SJH1 72 45 Yes 67.3 ± 4.7 148 ± 4
WK1 77 121 Yes 46.2 ± 1.0 150 ± 2
  1. Metadata for patient age and survival post-diagnosis along with retinoblastoma status, doubling time for the derived cell lines and median survival of mice carrying orthotopic tumours. RB pathway LOF Loss of function in one or more steps in the retinoblastoma tumour suppressor pathway. XG median survival Median survival for mice with orthotopic xenografts